{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:10:30Z","timestamp":1759032630276},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T00:00:00Z","timestamp":1269475200000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>Joshi G, Mick E, Wozniak J, Geller D, Park J, Strauss S, Biederman J. Impact of obsessive\u2010compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder.\u2028Bipolar Disord 2010: 12: 196\u2013204. \u00a9 2010 The Authors.\u2028Journal compilation \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Objective:\u2002<\/jats:bold> To compare antimanic response to olanzapine therapy in youth with bipolar disorder (BPD) based on the status of comorbidity with obsessive\u2010compulsive disorder (OCD).<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Secondary analysis of identically designed 8\u2010week open\u2010label trials of olanzapine therapy in youth with BPD. Severity of mania assessed with the Young Mania Rating Scale (YMRS) and Clinical Global Impression (CGI) scales.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Of the 52 BPD subjects (mean age 8.4\u2003\u00b1\u20033.1\u2003years) enrolled in the olanzapine trials (mean dose 8.5\u2003\u00b1\u20034.3\u2003mg\/day), 39% (n\u2003=\u200320) met criteria for comorbid OCD. Antimanic response in BPD subjects was significantly worse in the presence of comorbid OCD (YMRS mean reduction: \u2003\u22125.9\u2003\u00b1\u200313.1 versus \u2003\u221213.7\u2003\u00b1\u200318.8, p\u2003=\u20030.04; \u2265 30% reduction: 25% versus 63%, p\u2003=\u20030.008; CGI\u2010Improvement score \u2264 2: 25% versus 68%, p\u2003=\u20030.003). There was no difference in the rate of dropouts (50% versus 29%, p\u2003=\u20030.2) or adverse effects in BPD subjects with or without comorbid OCD.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Less than expected antimanic response to olanzapine therapy in the presence of comorbidity with OCD suggests that OCD is an important functionally impairing psychiatric comorbidity that may impact the efficacy of antimanic agents in youth with BPD. This study is limited by its design of secondary analysis of data from trials of an uncontrolled nature. Further prospective controlled trials are warranted.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2010.00789.x","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T11:55:24Z","timestamp":1269518124000},"page":"196-204","source":"Crossref","is-referenced-by-count":22,"title":["Impact of obsessive\u2010compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder"],"prefix":"10.1111","volume":"12","author":[{"given":"Gagan","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Mick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Geller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samara","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Biederman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.05.016"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-006-0658-2"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00128.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200312000-00016"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/104454602760219144"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/070674370104600902","article-title":"Anxiety disorders in consecutively referred children and adolescents with bipolar disorder: a neglected comorbidity","volume":"46","author":"Masi G","year":"2001","journal-title":"Can J Psychiatry"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.10.1679"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00043-8"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199708000-00012"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1999)10:1<18::AID-DA3>3.0.CO;2-R"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00004583-199007000-00016","article-title":"DSM\u2010III disorders in a large sample of adolescents","volume":"4","author":"McGee R","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199506000-00009"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200107000-00013"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1207"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0813"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000161648.82775.ee"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00461-5"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.03.019"},{"key":"e_1_2_7_20_2","volume-title":"Presented at the 158th Annual Meeting of the American Psychiatric Association","author":"Biederman J","year":"2005"},{"key":"e_1_2_7_21_2","article-title":"Olanzapine and topiramate in the treatment of pediatric bipolar disorder","author":"Wozniak J","year":"2007","journal-title":"Poster presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_7_23_2","volume-title":"Schedule for Affective Disorders and Schizophrenia for School\u2010Age Children Epidemiologic Version","author":"Orvaschel H","year":"1994"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200211000-00017"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1207\/S15374424JCCP3104_15"},{"key":"e_1_2_7_26_2","first-page":"839","article-title":"CGI (Clinical Global Impression) Scale\u2014NIMH","volume":"21","author":"National Institute of Mental Health","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1234-988X(199604)6:1<49::AID-MPR152>3.3.CO;2-7"},{"key":"e_1_2_7_30_2","first-page":"803","article-title":"DSM\u2010III\u2010R and pediatric psychopharmacology","volume":"21","author":"Rapoport JL","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_7_31_2","article-title":"Examining the clinical characteristics of comorbid bipolar disorder and obsessive\u2010compulsive disorder in children and adolescents","author":"Joshi G","year":"2006","journal-title":"Symposia presentation at the 53rd Annual Meeting of American Academy of Child and Adolescent Psychiatry"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.08.005"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0316"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.4.431"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0107"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2010.00789.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2010.00789.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:08:32Z","timestamp":1698746912000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2010.00789.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1399-5618.2010.00789.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2010.00789.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}